Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | CAMKK1 | Q8N5S9 | 2/20 | 0.54 |
| ▸ | CAMKK2 | Q96RR4 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | CASP1 | P29466 | 2/20 | 0.54 |
| ▸ | CASP7 | P55210 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.54 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.54 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.54 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.54 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.54 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.54 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16863801 | 1.00 | BCL2 (0.55) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL30278153 | 0.90 | BCL2 (0.53) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL12687849 | 0.86 | KMT2A (0.60) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL12687844 | 0.83 | BCL2 (0.57) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL16574973 | 0.82 | BCL2 (0.54) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL12478636 | 0.82 | BCL2 (0.68) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL13229867 | 0.81 | BCL2 (0.50) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL20110593 | 0.79 | KMT2A (0.63) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL20117736 | 0.79 | NQO2 (0.46) | BCL2KMT2AMEN1CAMKK1CAMKK2 | |
| SCHEMBL29422905 | 0.77 | KMT2A (0.66) | BCL2KMT2AMEN1CAMKK1CAMKK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11371085-B2 | Reagents and methods for isothermal chain reaction | MANCEBO RICARDO (US) | 2022-06-28 | — | — | US | claimed |
| CN-122095108-A | Multiplex detection combinations for detecting viral, bacterial and parasitic nucleic acids | — | 2026-05-26 | — | — | CN | disclosed |
| US-12637724-B2 | Compositions, kits and methods for detection of viral sequences | Life Technologies Corporation (US) | 2026-05-26 | — | — | US | disclosed |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | Singular Genomics Systems, Inc. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12630808-B2 | Modified archaeal family b polymerases | Singular Genomics Systems, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12595508-B2 | Nucleotide cleavable linkers and uses thereof | Singular Genomics Systems, Inc. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260085299-A1 | ENGINEERED PYROCOCCUS ENZYMES AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-12577271-B2 | Modified nucleotides and uses thereof | Singular Genomics Systems, Inc. (US) | 2026-03-17 | — | — | US | disclosed |
| US-11359232-B2 | Reagents and methods for autoligation chain reaction | Mancebo, Ricardo (US) | 2022-06-14 | — | — | US | disclosed |
| US-20220170092-A1 | METHODS FOR LONG READ SEQUENCING | FIRST-CITIZENS BANK & TRUST COMPANY | 2022-06-02 | — | — | US | disclosed |
| EP-3997101-A1 | NOVEL NUCLEOTIDE ANALOGUES AND METHODS FOR USE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-05-18 | — | — | EP | disclosed |
| CN-107760770-B | Compositions, methods and kits for nucleic acid synthesis and amplification | 生命技术公司 | 2022-05-17 | — | — | CN | disclosed |
| US-20220127299-A1 | NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF | LG ELECTRONICS INC. (KR) | 2022-04-28 | — | — | US | disclosed |
| US-20220119780-A1 | ENGINEERED PYROCOCCUS ENZYMES AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2022-04-21 | — | — | US | disclosed |
| US-20220119873-A1 | KARYOTYPING ASSAY | Life Technologies Corporation | 2022-04-21 | — | — | US | disclosed |
| US-20220119779-A1 | MODIFIED PYROCOCCUS POLYMERASES AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2022-04-21 | — | — | US | disclosed |
| WO-2022072374-A1 | LIGHT-CONTROLLED BIOORTHOGONAL TETRAZINE LIGATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-07 | — | — | WO | disclosed |
| US-11266673-B2 | Nucleotide derivatives and methods of use thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637724-B2 | Compositions, kits and methods for detection of viral sequences | SARS1, POLL, DDX41 | BCL2 3132/4885KMT2A 1790/4885MEN1 2544/4885 |
| US-12630808-B2 | Modified archaeal family b polymerases | SSU72, POLB, POLQ | BCL2 4655/4885KMT2A 308/4885MEN1 3513/4885 |
| US-12595508-B2 | Nucleotide cleavable linkers and uses thereof | NSUN2, CCRL2, NOP2 | BCL2 1244/4885KMT2A 2804/4885MEN1 4378/4885 |
| US-12577271-B2 | Modified nucleotides and uses thereof | NUDT1, NSUN2, CCRL2 | BCL2 1812/4885KMT2A 2809/4885MEN1 2476/4885 |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | NSUN2, POLR2H, POLH | BCL2 2182/4885KMT2A 2375/4885MEN1 2394/4885 |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | POLL, POLB, POLN | BCL2 3651/4885KMT2A 1209/4885MEN1 3638/4885 |
| US-20220127299-A1 | NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF | NUDT21, CPSF7, DCLRE1A | BCL2 3247/4885KMT2A 1435/4885MEN1 2454/4885 |
| US-20260085299-A1 | ENGINEERED PYROCOCCUS ENZYMES AND USES THEREOF | POLB, POLM, POLRMT | BCL2 4392/4885KMT2A 1696/4885MEN1 1571/4885 |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | DNMT3A, POLB, POLM | BCL2 4790/4885KMT2A 755/4885MEN1 2077/4885 |
| US-11266673-B2 | Nucleotide derivatives and methods of use thereof | POLRMT, NSUN2, NUDT1 | BCL2 4476/4885KMT2A 1863/4885MEN1 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.